Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Cancer statistics, 2009.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ.

CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006.

2.

Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study.

Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, Shoupe D, Berek JS, Hankinson S, Manson JE.

Obstet Gynecol. 2009 May;113(5):1027-37. doi: 10.1097/AOG.0b013e3181a11c64.

3.

Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study.

Green DM, Sklar CA, Boice JD Jr, Mulvihill JJ, Whitton JA, Stovall M, Yasui Y.

J Clin Oncol. 2009 May 10;27(14):2374-81. doi: 10.1200/JCO.2008.21.1839. Review.

4.

Clinical practice. Primary ovarian insufficiency.

Nelson LM.

N Engl J Med. 2009 Feb 5;360(6):606-14. doi: 10.1056/NEJMcp0808697. Review. No abstract available.

5.

A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.

Michelsen TM, Dørum A, Dahl AA.

Gynecol Oncol. 2009 Apr;113(1):128-33. doi: 10.1016/j.ygyno.2008.12.024. Review.

PMID:
19178933
6.

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.

Rebbeck TR, Kauff ND, Domchek SM.

J Natl Cancer Inst. 2009 Jan 21;101(2):80-7. doi: 10.1093/jnci/djn442.

7.

A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.

Fang CY, Cherry C, Devarajan K, Li T, Malick J, Daly MB.

Gynecol Oncol. 2009 Mar;112(3):594-600. doi: 10.1016/j.ygyno.2008.11.039.

8.

Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging.

Rocca WA, Shuster LT, Grossardt BR, Maraganore DM, Gostout BS, Geda YE, Melton LJ 3rd.

Womens Health (Lond). 2009 Jan;5(1):39-48. doi: 10.2217/17455057.5.1.39.

9.

Management of premature ovarian failure.

Panay N, Kalu E.

Best Pract Res Clin Obstet Gynaecol. 2009 Feb;23(1):129-40. doi: 10.1016/j.bpobgyn.2008.10.008. Review.

PMID:
19091633
10.

Increased cardiovascular mortality after early bilateral oophorectomy.

Rivera CM, Grossardt BR, Rhodes DJ, Brown RD Jr, Roger VL, Melton LJ 3rd, Rocca WA.

Menopause. 2009 Jan-Feb;16(1):15-23. doi: 10.1097/gme.0b013e31818888f7.

11.

Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.

Utian WH, Archer DF, Bachmann GA, Gallagher C, Grodstein Fn, Heiman JR, Henderson VW, Hodis HN, Karas RH, Lobo RA, Manson JE, Reid RL, Schmidt PJ, Stuenkel CA; North American Menopause Society..

Menopause. 2008 Jul-Aug;15(4 Pt 1):584-602. doi: 10.1097/gme.0b013e31817b076a.

12.

The influence of endocrine treatments for breast cancer on health-related quality of life.

Buijs C, de Vries EG, Mourits MJ, Willemse PH.

Cancer Treat Rev. 2008 Nov;34(7):640-55. doi: 10.1016/j.ctrv.2008.04.001. Review.

PMID:
18514425
13.

Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure.

van der Stege JG, Groen H, van Zadelhoff SJ, Lambalk CB, Braat DD, van Kasteren YM, van Santbrink EJ, Apperloo MJ, Weijmar Schultz WC, Hoek A.

Menopause. 2008 Jan-Feb;15(1):23-31.

PMID:
18257141
14.

Ovarian androgen production in postmenopausal women.

Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ.

J Clin Endocrinol Metab. 2007 Aug;92(8):3040-3.

PMID:
17519304
15.

IMS updated recommendations on postmenopausal hormone therapy.

Board of the International Menopause Society., Pines A, Sturdee DW, Birkhäuser MH, Schneider HP, Gambacciani M, Panay N.

Climacteric. 2007 Jun;10(3):181-94. No abstract available.

PMID:
17487645
16.

Effect of early menopause on bone mineral density and fractures.

Gallagher JC.

Menopause. 2007 May-Jun;14(3 Pt 2):567-71. Review.

PMID:
17476146
17.

Management of premature menopause.

Pitkin J, Rees MC, Gray S, Lumsden MA, Marsden J, Stevenson JC, Williamson J.

Menopause Int. 2007 Mar;13(1):44-5. Review.

PMID:
17448268
18.

Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

Walshe JM, Denduluri N, Swain SM.

J Clin Oncol. 2006 Dec 20;24(36):5769-79. Review.

PMID:
17130515
19.

Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.

Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ 3rd.

Lancet Oncol. 2006 Oct;7(10):821-8.

PMID:
17012044
20.

The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.

Madalinska JB, van Beurden M, Bleiker EM, Valdimarsdottir HB, Hollenstein J, Massuger LF, Gaarenstroom KN, Mourits MJ, Verheijen RH, van Dorst EB, van der Putten H, van der Velden K, Boonstra H, Aaronson NK.

J Clin Oncol. 2006 Aug 1;24(22):3576-82.

PMID:
16877724
Items per page

Supplemental Content

Support Center